Punitive Damages: FDA-Approved Drugs: HB 1093 (1991).
Expands 1990’s prohibition against seeking punitive damages in cases in
Expands 1990’s prohibition against seeking punitive damages in cases in which FDA approved drugs are administered by a physician, to include medically prescribed drugs or products used on an experimental basis (when such experimental use has not received specific FDA approval) and when the patient has given informed consent.
Latest News
View all news
Groups Urge Congressional Scrutiny of D.C. Attorney General’s Use of Private Attorneys
Concerns Mount Over Outside Counsel Contracts and Litigation Agendas
America’s $367 Billion Lawsuit Epidemic
The Hidden Tax Crushing Families and Businesses
$745 Million Verdict in Coastal Litigation Exemplifies Louisiana’s ‘Judicial Hellhole®’ Status
Excessive Litigation Costs Residents $1,011 Annually and Jeopardizes 40,000 Jobs Each Year
Alarming Expansion in Public Nuisance Litigation Revealed by ATRA Report
From Social Media to Car Thefts, New Litigation Trends Threaten Entire Industries
Georgia Legislature Passes Landmark Tort Reform Bill
ATRA Applauds Passage, Anticipates Governor’s Signature on SB 68
The trial lawyer playbook: How aggressive advertising and junk science are costing Californians
In 2024, legal services ads hit $164 million in LA, part of a 39% national rise, fueling aggressive marketing, third-party funding, and straining California’s economy and courts.